Katriona J.M. Brooksbank

May 7, 2024 | onlinelibrary.wiley.com | Jaclyn Carberry |Mark C. Petrie |Matthew Lee |Katriona J.M. Brooksbank

Introduction The widespread utilization of emergency reperfusion therapy and advances in pharmacological secondary prevention have substantially improved survival rates following an acute myocardial infarction (MI).1, 2 However, some patients still develop heart failure in the weeks, months, and years that follow.2 As the development of heart failure is associated with substantial morbidity and mortality, its prevention is an important therapeutic goal.3 The pathological precursor to heart...